Martijn Meijerink, MD, PhD, of Amsterdam UMC, discusses his recent research presented at the 2024 American Society of Clinical Oncology Annual Meeting evaluating the noninferiority of thermal ablation compared with surgical resection for patients with resectable colorectal liver metastases ≤3 cm.
Dr. Meijerink explains the rationale behind this analysis and highlights quality of life metrics, particularly in terms of recovery times, post-procedure pain, and return to normal activities.